Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies

被引:164
|
作者
Steinbach, Silke [1 ]
Hummel, Thomas
Boehner, Christina
Berktold, Sabina
Hundt, Walter
Kriner, Monika
Heinrich, Petra
Sommer, Harald
Hanusch, Claus
Prechtl, Anita
Schmidt, Burghart
Bauerfeind, Ingo
Seck, Katharina
Jacobs, Volker R.
Schmalfeldt, Barbara
Harbeck, Nadia
机构
[1] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, D-01307 Dresden, Germany
关键词
ODOR IDENTIFICATION; OLFACTORY THRESHOLDS; GUSTATORY FUNCTION; DISCRIMINATION; PREVENTION; PERCEPTION; FLAVOR; TESTS; CELLS; TRIAL;
D O I
10.1200/JCO.2008.19.2690
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Smell and taste changes during chemotherapy are significant complaints of cancer patients. Loss of olfactory/gustatory function can lead to malnutrition, weight loss, and possibly a prolonged morbidity of chemotherapy-induced adverse effects, decreased quality of life, poor compliance, and even decreased therapy response. This prospective study comprehensively investigated, to our knowledge for the first time, smell and taste changes in a cohort of 87 patients undergoing chemotherapy for breast cancer or gynecologic malignancies. Patients and Methods Olfactory function was tested using Sniffin' Sticks (Burghart; Wedel, Germany) and gustatory function was tested using taste strips before, during, and immediately and 3 months after chemotherapy. Results Olfactory and gustatory function significantly decreased during chemotherapy and recovered almost completely 3 months after chemotherapy. Scores of odor thresholds were affected more than those of discrimination or identification. The olfactory function of older patients was affected more than that of younger patients. There was no difference in the olfactory function during chemotherapy with respect to the chemotherapeutic agent or initial diagnosis (breast or ovarian cancer). Regarding taste, scores of salty taste were affected more than scores of sweet, sour, or bitter taste. The gustatory function did not differ significantly during chemotherapy with respect to age or diagnosis but did differ with respect to the chemotherapeutic agent. Taxane-based chemotherapy caused the most severe disorders. Conclusion Chemotherapy has a significant but transient effect on olfactory and gustatory function, possibly causing reduced appetite, a low energy intake, and weight loss. Additional spices and flavoring may compensate for this diminished chemosensory function, enhancing patient compliance and quality of life.
引用
收藏
页码:1899 / 1905
页数:7
相关论文
共 50 条
  • [21] Chemoterapy induced taste and smell changes in pediatric cancer patients
    Karaman, Nurseven
    Sari, Neriman
    Ergurhan Ilhan, Inci
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2013, 28 (03): : 101 - 104
  • [22] Impact of cancer chemotherapy-related taste and smell changes on daily life
    Bernhardson, B.
    Tishelman, C.
    Rutqvist, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 435 - 435
  • [23] Chemotherapy adversely impacts sleep quality in patients with gynecologic and breast malignancies
    Beffa, L. B.
    Cantillo, E.
    Wang, C. F.
    Luis, C.
    Mendez, H.
    Raker, C.
    Stuckey, A. R.
    Sikov, W. M.
    Robison, K. M.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 197 - 197
  • [24] Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changes
    Drareni, K.
    Dougkas, A.
    Giboreau, A.
    Laville, M.
    Souquet, P. J.
    Nazare, J. A.
    Fournel, P.
    Bensafi, M.
    LUNG CANCER, 2023, 177 : 29 - 36
  • [25] An investigation of taste alteration in patients undergoing cancer chemotherapy
    Rea, Teresa
    Esposito, Maria R.
    Simeone, Silvio
    Guillari, Assunta
    Tessitore, Grazia
    Lanzuise, Aniello
    Bosco, Giulia
    Gargiulo, Gianpaolo
    Coratella, Cesira
    Scarlata, Francesco
    Serra, Nicola
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2018, 177 (10) : 509 - 517
  • [26] Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
    N Tsavaris
    C Kosmas
    M Vadiaka
    P Kanelopoulos
    D Boulamatsis
    British Journal of Cancer, 2002, 87 : 21 - 27
  • [27] Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
    Tsavaris, N
    Kosmas, C
    Vadiaka, M
    Kanelopoulos, P
    Boulamatsis, D
    BRITISH JOURNAL OF CANCER, 2002, 87 (01) : 21 - 27
  • [28] Chemosensory changes experienced by patients undergoing cancer chemotherapy: A qualitative interview study
    Bernhardson, Britt-Marie
    Tishelman, Carol
    Rutqvist, Lars Erik
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 34 (04) : 403 - 412
  • [29] Breast cancer risk in patients after treatment for gynecologic malignancies
    Miller, BE
    CANCER JOURNAL, 2001, 7 (06): : 541 - 541
  • [30] Quantitative MRI assessment of uninvolved breast tissue in patients with locally-advanced breast cancer undergoing neoadjuvant chemotherapy.
    Klifa, C. S.
    Gibbs, J.
    Hattangadi, J.
    Hylton, N.
    CANCER RESEARCH, 2009, 69 (02) : 256S - 256S